Literature DB >> 12515079

Update on pseudophakic cystoid macular edema treatment options.

Darrin S Levin1, Jennifer I Lim.   

Abstract

As far as the treatment of chronic pseudophakic CME is concerned, it is important to understand that postoperative CME usually resolves with time. One must gauge the various treatment modalities outlined above with improvements in visual acuity and decreasing clinical macular thickening. Mild cases usually require no treatment, whereas those that entail clinically significant reductions in vision or macular thickening do require appropriate intervention.

Entities:  

Mesh:

Year:  2002        PMID: 12515079     DOI: 10.1016/s0896-1549(02)00041-x

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  5 in total

1.  Intravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group.

Authors:  Lihteh Wu; J Fernando Arevalo; Erick Hernandez-Bogantes; José A Roca
Journal:  Int Ophthalmol       Date:  2012-04-08       Impact factor: 2.031

2.  Improvement of pseudophakic cystoid macular edema with subconjunctival injections of interferon α2b:a case report.

Authors:  Hossein Aghaei; Acieh Es'haghi; Rama Pourmatin
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-23

3.  Short-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edema.

Authors:  Waseem M Al Zamil
Journal:  Saudi J Ophthalmol       Date:  2014-10-30

4.  Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.

Authors:  Alejandro Gonzalez-De la Rosa; Jose Navarro-Partida; Juan Carlos Altamirano-Vallejo; Ada Gabriela Hernandez-Gamez; Jesus Javier Garcia-Bañuelos; Juan Armendariz-Borunda; Arturo Santos
Journal:  J Ocul Pharmacol Ther       Date:  2019-01-07       Impact factor: 2.671

5.  Intravitreal bevacizumab for pseudophakic cystoid macular edema; a systematic review.

Authors:  Khalil Ghasemi Falavarjani; Mohammad-Mehdi Parvaresh; Mehdi Modarres; Masih Hashemi; Nasrollah Samiy
Journal:  J Ophthalmic Vis Res       Date:  2012-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.